+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Aminoglycosides Market by Product (Amikacin, Gentamicin, Kanamycin), Route of Administration (Injectables, Oral, Topical), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977762
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Aminoglycosides Market grew from USD 1.93 billion in 2023 to USD 2.02 billion in 2024. It is expected to continue growing at a CAGR of 4.76%, reaching USD 2.67 billion by 2030.

These antibiotics are essential for treating severe bacterial infections, especially those caused by gram-negative bacteria, due to their mechanism of inhibiting bacterial protein synthesis. Aminoglycosides are extensively used in human healthcare settings such as hospitals and clinics and are vital in veterinary medicine for treating animal infections. Despite their crucial role, the market growth faces hurdles due to the serious side effects of nephrotoxicity and ototoxicity associated with these drugs, competition from newer antibiotics, the escalating issue of antibiotic resistance, and stringent regulatory environments. Nevertheless, the market is driven by increasing incidences of multidrug-resistant bacterial infections, enhancements in global healthcare infrastructures, continuous research and development efforts, and supportive governmental healthcare policies. Next-generation advancements, such as the development of safer derivatives and advanced drug delivery systems, are crucial for expanding the utility and effectiveness of aminoglycosides, thereby supporting their continued demand in the fight against challenging bacterial infections.

Regional Insights

In North America, particularly the United States and Canada, aminoglycosides are tightly regulated and mainly prescribed for severe infections in a hospital setting due to their potential side effects on the kidneys and ears. In Latin America, access to healthcare and antibiotics varies significantly between countries. In Europe, the use of aminoglycosides is also well-regulated, with strict guidelines in place to prevent over-prescription and manage antibiotic resistance. European health agencies monitor antibiotic use closely, promoting prudent use to lower resistance rates. In the Middle East and Africa, however, there are varying healthcare access levels and differences in the regulatory environment. In countries such as Japan, Australia, and South Korea, healthcare systems are robust, and the use of antibiotics is strictly controlled similar to Europe.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Aminoglycosides Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rise in need for effective treatments for gram-negative bacterial infections
  • Utilization veterinary medicine to treat infections in animals

Market Restraints

  • Complexities in development and manufacturing of aminoglycosides

Market Opportunities

  • Advancements in drug delivery systems for aminoglycosides
  • Research and development into aminoglycoside resistance mechanisms

Market Challenges

  • Side effects and toxicity caused due to aminoglycosides

Market Segmentation Analysis

  • Product: Wide utilization of gentamicin to treat infections in the blood, abdomen, lungs, skin, and soft tissues
  • Application: Employment of aminoglycosides across respiratory diseases

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aminoglycosides Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aminoglycosides Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cipla Limited Unveils Plazomicin for Advanced Urinary Tract Infection Management in India

Cipla Limited received approval from the Central Drugs Standard Control Organization (CDSCO) to distribute plazomicin, an innovative aminoglycoside antibiotic, across India. Designed for intravenous administration, plazomicin effectively addresses complicated urinary tract infections (cUTI), including pyelonephritis. Such health concerns affect roughly 150 million individuals globally each year, and the rise of antibiotic-resistant pathogens significantly complicates treatment options.

Innovating Aminoglycoside Antibiotics for Enhanced Safety: Mitigating Hearing Loss Risks

Discovery Research Grant and the team at Stanford University have embarked on a groundbreaking project aimed at developing safer aminoglycoside antibiotics that mitigate the risk of hearing loss without compromising their antibacterial effectiveness. This initiative, supported jointly by the Cystic Fibrosis Trust, targets modifying the chemical structure of existing aminoglycosides to prevent them from entering the inner ear's hair cells, which is the primary cause of ototoxicity. Despite their efficacy in treating infections, especially in vulnerable populations like premature infants and cystic fibrosis patients, traditional aminoglycosides pose significant hearing loss risks, affecting approximately 20% of users.

BDR Pharmaceuticals Launches Nilotinib: A Novel Approach in the Treatment of Rare Childhood and Adult Leukemia

BDR Pharmaceuticals launched Nilotinib, developed for treating Philadelphia chromosome-positive (Ph+) leukemia, a rare subtype of acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML). The introduction of Nilotinib marks a significant advancement in treating this challenging condition. Clinical trials have revealed the drug's profound effectiveness, showcasing major molecular responses and significantly enhanced survival rates for patients.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aminoglycosides Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Aminoglycosides Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bristol Myers Squibb Company, Cipla Limited, GlaxoSmithKline plc, Hangzhou Uniwise International Co., Ltd., HuvePharma, Insmed Incorporated, Jiangxi Bolai Pharmacy Co., Ltd., Kremoint Pharma Pvt. Ltd, Medico Remedies Pvt. Ltd., Medson Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Vega Pharma Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aminoglycosides Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Amikacin
  • Gentamicin
  • Kanamycin
  • Neomycin
  • Paromomycin
  • Streptomycin
  • Tobramycin

Route of Administration

  • Injectables
  • Oral
  • Topical

Application

  • Respiratory Diseases
  • Skin Infection
  • UTI & Pelvic Diseases
  • Veterinary Medicine

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in need for effective treatments for gram-negative bacterial infections
5.1.1.2. Utilization veterinary medicine to treat infections in animals
5.1.2. Restraints
5.1.2.1. Complexities in development and manufacturing of aminoglycosides
5.1.3. Opportunities
5.1.3.1. Advancements in drug delivery systems for aminoglycosides
5.1.3.2. Research and development into aminoglycoside resistance mechanisms
5.1.4. Challenges
5.1.4.1. Side effects and toxicity caused due to aminoglycosides
5.2. Market Segmentation Analysis
5.2.1. Product: Wide utilization of gentamicin to treat infections in the blood, abdomen, lungs, skin, and soft tissues
5.2.2. Application: Employment of aminoglycosides across respiratory diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Aminoglycosides Market, by Product
6.1. Introduction
6.2. Amikacin
6.3. Gentamicin
6.4. Kanamycin
6.5. Neomycin
6.6. Paromomycin
6.7. Streptomycin
6.8. Tobramycin
7. Aminoglycosides Market, by Route of Administration
7.1. Introduction
7.2. Injectables
7.3. Oral
7.4. Topical
8. Aminoglycosides Market, by Application
8.1. Introduction
8.2. Respiratory Diseases
8.3. Skin Infection
8.4. UTI & Pelvic Diseases
8.5. Veterinary Medicine
9. Americas Aminoglycosides Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Aminoglycosides Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Aminoglycosides Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Cipla Limited Unveils Plazomicin for Advanced Urinary Tract Infection Management in India
12.3.2. Innovating Aminoglycoside Antibiotics for Enhanced Safety: Mitigating Hearing Loss Risks
12.3.3. BDR Pharmaceuticals Launches Nilotinib: A Novel Approach in the Treatment of Rare Childhood and Adult Leukemia
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. AMINOGLYCOSIDES MARKET RESEARCH PROCESS
FIGURE 2. AMINOGLYCOSIDES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AMINOGLYCOSIDES MARKET DYNAMICS
FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AMINOGLYCOSIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY KANAMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PAROMOMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PAROMOMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY UTI & PELVIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY UTI & PELVIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 70. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 71. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. INDIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 104. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 105. INDIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. INDIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 111. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 116. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 117. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 123. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 135. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 141. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 147. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 159. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 172. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 173. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 178. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 179. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 190. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 191. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 196. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 197. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 203. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 208. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 209. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 215. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 221. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. POLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. POLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 232. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 233. POLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. POLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. QATAR AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. QATAR AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 238. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 239. QATAR AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. QATAR AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 245. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 262. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 263. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 269. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 275. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 280. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 281. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 296. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • AbbVie Inc.
  • AstraZeneca plc
  • Bristol Myers Squibb Company
  • Cipla Limited
  • GlaxoSmithKline plc
  • Hangzhou Uniwise International Co., Ltd.
  • HuvePharma
  • Insmed Incorporated
  • Jiangxi Bolai Pharmacy Co., Ltd.
  • Kremoint Pharma Pvt. Ltd
  • Medico Remedies Pvt. Ltd.
  • Medson Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Vega Pharma Ltd.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.67 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Aminoglycosides Global Market Report 2024 - Product Image

Aminoglycosides Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Aminoglycosides Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Aminoglycosides Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 73 Pages
  • Global
From
Global Antibacterial Drugs Market by Routes of Administration (Enteral, Parenteral), Drug Class (Aminoglycoside, B - Lactams, Macrolides), Distribution Channel - Forecast 2024-2030 - Product Image

Global Antibacterial Drugs Market by Routes of Administration (Enteral, Parenteral), Drug Class (Aminoglycoside, B - Lactams, Macrolides), Distribution Channel - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Antibiotic Residue Test Kits Market by Product Type (Aminoglycosides, Amphenicols, Beta-Lactams), End User (Food & Beverages Industry, Independent Laboratories, Veterinary) - Forecast 2024-2030 - Product Image

Global Antibiotic Residue Test Kits Market by Product Type (Aminoglycosides, Amphenicols, Beta-Lactams), End User (Food & Beverages Industry, Independent Laboratories, Veterinary) - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Kanamycin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Kanamycin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From

About the Aminoglycosides Market

Aminoglycosides are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from natural sources, such as soil bacteria, and are effective against Gram-negative bacteria. Aminoglycosides work by inhibiting protein synthesis in bacteria, which prevents them from replicating and spreading. They are often used in combination with other antibiotics to treat more serious infections. Aminoglycosides are commonly used in hospitals and other healthcare settings, as well as in the treatment of serious infections in the community. They are also used in veterinary medicine. The aminoglycosides market is highly competitive, with a number of companies offering a range of products. Major players in the market include Merck & Co., Pfizer, Sanofi, Novartis, and Bayer. Other companies in the market include Allergan, AstraZeneca, GlaxoSmithKline, and Eli Lilly. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.